ナノプラスチックは,ドロソフィラの腸内整合性を破壊することによって,鉛曝露による発達神経毒性を悪化させます
Xiaoxiao Luo1, Ke Zhang1, Kaishun Chen2
1The Key Laboratory of Modern Toxicology of Ministry of Education, Department of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
Neurotoxicology
|February 15, 2026
まとめ
ナノプラスチック (NP) と鉛 (Pb) の併用暴露は,ハエの神経発達毒性および学習欠陥を著しく悪化させる. この相乗効果は,環境汚染物質によるリスクを強調しています.
科学分野:
- 環境毒理学 環境毒理学
- 神経科学は神経科学である.
- 発達生物学 発達生物学とは
背景:
- 鉛 (Pb) は中枢神経系に蓄積する神経毒重金属です.
- マイクロナノプラスチック (MNPs) はPbを吸収し,その毒性を潜在的に高めます.
- 併用曝露による神経発達のシナージスティックな効果は十分に理解されていません.
研究 の 目的:
- 組み合わせたナノプラスチック (NP) とPbの曝露による神経発達の毒性を評価する.
- 協同作用の有毒性の根本的なメカニズムを調査する.
- 複合汚染物質のリスクを評価するためのドロソフィラモデルを確立する.
主な方法:
- 毒性評価のためにDrosophila melanogasterモデルを使用しました.
- 行動テスト (学習,記憶,運動活動,発達率) を実施.
- 機械的調査 (Pbの蓄積,酸化ストレスマーカー,NMJ,MB,腸損傷) を実施しました.
主要な成果:
- 併用暴露は,学習/記憶の欠陥を悪化させ,発達率を低下させ,雌のハエの生存率を低下させた.
- 神経組織におけるPbの蓄積はNPによって促進された.
- 酸化ストレス,NMJ/MB障害,および腸内損傷は,共曝露によって悪化した.
結論:
- NPは,複数の経路を通じて,Pb誘発の神経発達毒性をシネギスティックに強化します.
- この研究は,環境複合汚染物質に関連した健康リスクの証拠を提供します.
- この調査結果は,リスク評価において組み合わせ効果を考慮することの重要性を強調しています.
関連する概念動画
Types of Toxins
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
CNS Stimulants: Psychedelic Agents
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...


